National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

Publication Date

2014

Journal Title

Circulation

Abstract

Background Anticoagulation control with warfarin, as assessed by the international normalized ratio (INR), is challenging. Time in the therapeutic range has been inversely correlated with major hemorrhage, thrombosis, and mortality. Quest Diagnostics offers standardized INR laboratory testing services to approximately half of US physician practices. To inform national stroke prevention strategies, we evaluated anticoagulation control in office-based community practices. Methods and Results We selected individuals with 2 months of INR data, INR results of >1.2, and an ICD-9 diagnosis code of atrial fibrillation. Frequency of INR testing and time in the therapeutic range were analyzed by age, sex, length of testing period, number of referred patients per provider, and median household income (based on home ZIP code). We identified 138 319 individuals referred by 37 939 physicians, yielding a total of 2 683 674 INR results. Patients had a mean age of 74 years; 81% were 65 years of age, and 55% were 75 years of age. The mean time in the therapeutic range was 53.7% overall and improved with time on treatment, increasing from 47.6% for patients with57.5% for those with 6 months of testing (P

Volume Number

129

Issue Number

13

Pages

1407-1414

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

General Internal Medicine

PMID

24493817

DOI

10.1161/circulationaha.113.002601

For the public and Northwell Health campuses

Share

COinS